SURF — Surface Oncology Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $65.08m
- $8.82m
- $30.00m
U.S. STOCKS ON THE MOVE-Walgreens, Baidu, Masimo Corp
Surface Oncology surges on $30 mln milestone payment
Brief: Surface Oncology Achieves $30 Mln Milestone With First Patient Dosed In Glaxosmithkline Phase 1 Study
Brief: Surface Oncology - Revenue Recognized In Q4 Ended Dec 31, 2021, Was $0.2 Million, Compared To Revenue Of $87.6 Million For Same Period In 2020
Brief: Surface Oncology Appoints Denice Torres As Chair Of The Board Of Directors
Brief: Surface Oncology Presents Promising Clinical Data On Srf617 At The European Society For Medical Oncology Immuno-Oncology Congress (Esmo-Io) 2021
Brief: Surface Oncology To Present New Clinical Data From Tumor Treatment Trial
Surface Oncology rises as U.S. FDA allows antibody clinical trial
Brief: Surface Oncology Announces FDA Clearance Of IND Application For Gsk4381562, A Novel Antibody Targeting Pvrig
Brief: Surface Oncology Presents Preclinical Data On Lead Clinical Programs
Surface Oncology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Surface Oncology Reports Financial Results And Corporate Highlights For Third Quarter 2021
Brief: Surface Oncology Announces Phase 2 Study Testing SRF388 In Hepatocellular Carcinoma With Roche
Brief: Surface Oncology Inc Says Co Entered Into A First Amendment To Loan And Security Agreement Dated November 19, 2019
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology Inc Files For Mixed Shelf Of Upto $300 Million
Brief: Surface Oncology Appoints Denice Torres To Board Of Directors
U.S. STOCKS ON THE MOVE-Comstock, DocuSign, Adial, The9
Surface Oncology: Rises on Roche tie-up to study liver cancer therapy